To view the PDF file, sign up for a MySharenet subscription.

ASCENDIS HEALTH LIMITED - Dealings in securities by an associate of a director

Release Date: 29/01/2019 13:25
Code(s): ASC     PDF:  
Wrap Text
Dealings in securities by an associate of a director

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis” or “the Company”)


Dealings in securities by an associate of a director


In terms of paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the following
information, relating to dealings in securities by an associate of a director, is disclosed:

Name of director:                   Gary Shayne (non-executive)

Name of associate:                  Gane Holdings Proprietary Limited (“Gane Holdings”)

Nature and extent of interest:      Indirect beneficial – through Gane Holdings, in which Gary
                                    Shayne holds an indirect controlling shareholding through the
                                    ultimate holding company, Coast2Coast Communications
                                    Limited (“C2C”)

Nature of transactions:             Involuntary sale, on market, as a result of forced sales actioned
                                    by financial institutions due to the shares being linked to equity
                                    finance transactions resulting in margin calls.

                                    In terms of paragraph 3.70 of the JSE Listings Requirements,
                                    the JSE has granted a waiver in respect of dealings in the
                                    Company’s shares in a closed period by associates of Mr G
                                    Shayne. Mr G Shayne has no discretion in respect of these
                                    dealings due to the trades being forced sales actioned by
                                    financial institutions as a result of the shares being linked to
                                    equity finance transactions resulting in margin calls where C2C
                                    has not fulfilled such margin calls. This results in the financial
                                    institutions exercising their rights to sell a sufficient number of
                                    the Company’s shares held by them as security and as such,
                                    protect their loans to C2C.

Class of shares:                    Ordinary shares
Written clearance obtained:         Clearance was obtained from the Chairman
Trade 1:
Date of transaction:                23 January 2019
Number of shares:                   19,426
Price per share (low):              R5.75

Price per share (high):             R5.77
Volume weighted average price:      R5.7593
Value:                              R111,880.16
Trade 2:
Date of transaction:               24 January 2019
Number of shares:                  41,964
Price per share (low):             R5.50
Price per share (high):            R5.67
Volume weighted average price:     R5.5862
Value:                             R234,419.30
Trade 3:
Date of transaction:               25 January 2019
Number of shares:                  48,232
Price per share (low):             R5.60
Price per share (high):            R5.79
Volume weighted average price:     R5.7577
Value:                             R277,705.39
Trade 4:
Date of transaction:               28 January 2019
Number of shares:                  218,604
Price per share (low):             R5.43
Price per share (high):            R5.56
Volume weighted average price:     R5.5043
Value:                             R1,203,262.00




Bryanston
29 January 2019

Sponsor
Questco Corporate Advisory Proprietary Limited

Date: 29/01/2019 01:25:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story